Epigenetic dysregulation of TET2 in human glioblastoma

30Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

Ten-eleven translocation (TET) enzymes are frequently deregulated in cancer, but the underlying molecular mechanisms are still poorly understood. Here we report that TET2 shows frequent epigenetic alterations in human glioblastoma including DNA hypermethylation and hypo-hydroxymethylation, as well as loss of histone acetylation. Ectopic overexpression of TET2 regulated neural differentiation in glioblastoma cell lines and impaired tumor growth. Our results suggest that epigenetic dysregulation of TET2 plays a role in human glioblastoma.

Cite

CITATION STYLE

APA

García, M. G., Carella, A., Urdinguio, R. G., Bayón, G. F., Lopez, V., Tejedor, J. R., … Fraga, M. F. (2018). Epigenetic dysregulation of TET2 in human glioblastoma. Oncotarget, 9(40), 25922–25934. https://doi.org/10.18632/oncotarget.25406

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free